DVAX
Income statement / Annual
Last year (2023), Dynavax Technologies Corporation's total revenue was $232.28 M,
a decrease of 67.86% from the previous year.
In 2023, Dynavax Technologies Corporation's net income was -$6.39 M.
See Dynavax Technologies Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$232.28 M
|
$722.68 M
|
$439.44 M
|
$46.55 M
|
$35.22 M
|
$8.20 M
|
$327,000.00
|
$11.04 M
|
$4.05 M
|
$11.03 M
|
| Cost of Revenue |
$50.17 M |
$262.15 M |
$173.57 M |
$13.91 M |
$19.39 M |
$21.80 M |
$1.19 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$182.12 M |
$460.53 M |
$265.87 M |
$32.64 M |
$15.83 M |
-$13.60 M |
-$867,000.00 |
$11.04 M |
$4.05 M |
$11.03 M |
| Gross Profit Ratio |
0.78 |
0.64 |
0.61 |
0.7 |
0.45 |
-1.66 |
-2.65 |
1 |
1 |
1 |
| Research and Development
Expenses |
$54.89 M
|
$46.60 M
|
$32.23 M
|
$28.61 M
|
$62.33 M
|
$74.95 M
|
$64.99 M
|
$84.49 M
|
$86.94 M
|
$84.58 M
|
| General & Administrative
Expenses |
$152.95 M
|
$131.41 M
|
$100.16 M
|
$79.26 M
|
$48.72 M
|
$64.77 M
|
$27.37 M
|
$37.26 M
|
$22.18 M
|
$17.76 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$24.76 M
|
$26.27 M
|
$31.76 M
|
$7.61 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$152.95 M
|
$131.41 M
|
$100.16 M
|
$79.26 M
|
$74.99 M
|
$64.77 M
|
$27.37 M
|
$37.26 M
|
$22.18 M
|
$17.76 M
|
| Other Expenses |
$11.31 M |
$7.80 M |
$8.66 M |
$6.81 M |
$3.35 M |
-$70,000.00 |
-$486,000.00 |
-$2.49 M |
$317,000.00 |
$433,000.00 |
| Operating Expenses |
$219.15 M |
$178.01 M |
$132.38 M |
$107.86 M |
$137.32 M |
$139.72 M |
$93.55 M |
$121.75 M |
$109.12 M |
$102.34 M |
| Cost And Expenses |
$269.31 M |
$440.16 M |
$305.96 M |
$121.77 M |
$156.71 M |
$161.52 M |
$93.55 M |
$121.75 M |
$109.12 M |
$102.34 M |
| Interest Income |
$31.99 M |
$7.91 M |
$140,000.00 |
$1.26 M |
$3.37 M |
$3.83 M |
$1.34 M |
$755,000.00 |
$205,000.00 |
$191,000.00 |
| Interest Expense |
$6.76 M |
$6.73 M |
$11.18 M |
$19.06 M |
$16.98 M |
$9.34 M |
$0.00 |
$0.00 |
$572,000.00 |
$35,000.00 |
| Depreciation &
Amortization |
$7.28 M
|
$6.67 M
|
$7.01 M
|
$9.34 M
|
$21.53 M
|
$14.48 M
|
$4.44 M
|
$2.26 M
|
$1.37 M
|
$1.40 M
|
| EBITDA |
$9.67 M
|
$307.70 M
|
$95.71 M
|
-$46.84 M
|
-$114.09 M
|
-$135.08 M
|
-$90.72 M
|
-$110.19 M
|
-$104.86 M
|
-$89.28 M
|
| EBITDA Ratio |
0.04 |
0.41 |
0.32 |
-1.44 |
-3.26 |
-18.24 |
-272.92 |
-10.03 |
-25.82 |
-8.22 |
| Operating Income Ratio
|
-0.16
|
0.39
|
0.31
|
-1.62
|
-3.45
|
-18.7
|
-293.59
|
-10.03
|
-25.94
|
-8.28
|
| Total Other
Income/Expenses Net |
$32.66 M
|
$10.78 M
|
-$56.97 M
|
-$6.87 M
|
-$17.76 M
|
-$5.58 M
|
$851,000.00
|
-$1.74 M
|
-$1.72 M
|
$589,000.00
|
| Income Before Tax |
-$4.37 M |
$294.30 M |
$77.52 M |
-$75.24 M |
-$152.60 M |
-$158.90 M |
-$95.15 M |
-$112.44 M |
-$106.79 M |
-$90.72 M |
| Income Before Tax Ratio
|
-0.02
|
0.41
|
0.18
|
-1.62
|
-4.33
|
-19.38
|
-290.99
|
-10.18
|
-26.37
|
-8.22
|
| Income Tax Expense |
$2.02 M |
$1.14 M |
$808,000.00 |
$16.54 M |
-$1.20 M |
$3.76 M |
$1.45 M |
-$3.01 M |
-$476,000.00 |
-$936,000.00 |
| Net Income |
-$6.39 M |
$293.16 M |
$76.71 M |
-$91.78 M |
-$151.40 M |
-$158.90 M |
-$95.15 M |
-$112.44 M |
-$106.79 M |
-$90.72 M |
| Net Income Ratio |
-0.03 |
0.41 |
0.17 |
-1.97 |
-4.3 |
-19.38 |
-290.99 |
-10.18 |
-26.37 |
-8.22 |
| EPS |
-0.0496 |
2.32 |
0.62 |
-0.91 |
-2.1 |
-2.55 |
-1.81 |
-2.92 |
-3.25 |
-3.45 |
| EPS Diluted |
-0.0496 |
1.97 |
0.54 |
-0.91 |
-2.1 |
-2.55 |
-1.81 |
-2.92 |
-3.25 |
-3.45 |
| Weighted Average Shares
Out |
$128.73 M
|
$126.40 M
|
$116.26 M
|
$100.75 M
|
$72.02 M
|
$62.36 M
|
$52.61 M
|
$38.51 M
|
$32.88 M
|
$26.29 M
|
| Weighted Average Shares
Out Diluted |
$128.73 M
|
$150.80 M
|
$133.01 M
|
$100.75 M
|
$72.02 M
|
$62.36 M
|
$52.61 M
|
$38.51 M
|
$32.88 M
|
$26.29 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
